Ifm Investors Pty LTD Repligen Corp Transaction History

Ifm Investors Pty LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$120.0 - $182.95 $53,520 - $81,595	-446 Reduced 3.98%	10,747 $1.35 Million
Q1 2024 Apr 22, 2024	BUY	$170.78 - $208.42 $94,441 - $115,256	553 Added 5.2%	11,193 $2.06 Million
Q3 2023 Oct 26, 2023	SELL	$138.78 - $176.51 $23,037 - $29,300	-166 Reduced 1.54%	10,640 $1.69 Million
Q2 2023 Jul 27, 2023	BUY	$138.42 - $180.31 $27,545 - $35,881	199 Added 1.88%	10,806 $1.53 Million
Q1 2023 May 11, 2023	BUY	$154.26 - $198.1 $16,660 - $21,394	108 Added 1.03%	10,607 $1.79 Million
Q4 2022 Feb 14, 2023	BUY	$162.42 - $220.56 $1.71 Million - $2.32 Million	10,499 New	10,499 $1.78 Million

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.02B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Ifm Investors Pty LTD, based on Form 13F filings with the SEC.

Stay updated on Ifm Investors Pty LTD with notifications on news.